ALGS

Aligos Therapeutics Inc.

Price

$6.73

return (12m)

-38.93%

p/e

-0.90

p/bv

2.14

DIVIDEND YIELD

0.00%

ALGS price

Aligos Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment ALGS

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

54.54%

3 months

17.45%

1 year

-38.93%

2 years

-48.43%

5 years

-98.37%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals ALGS

Valuation

P/E

-0.90

Sector -4.26

Industry -4.26

P/BV

2.14

Sector 2.11

Industry 2.11

P/Revenue (PSR)

18.22

Sector 2.08

Industry 2.08

EV/EBITDA

Sector -546.19

Industry -546.19

EV/EBIT

Sector -37.31

Industry -37.31

P/EBITDA

Sector -50.76

Industry -50.76

P/EBIT

Sector -39.62

Industry -39.62

P/Total Assets

1.03

Sector 1.25

Industry 1.25

P/Net Current Assets

2.46

Sector -5.47

Industry -5.47

P/Working Capital

2.02

Sector -1.10

Industry -1.10

EPS

-7.60

Sector -1.94

Industry -1.94

BVPS

3.19

Sector 1.89

Industry 1.89

Efficiency

Gross Margin

100.00%

Sector 38.90%

Industry 38.90%

EBITDA Margin

Sector -13,872.56%

Industry -13,872.56%

EBIT Margin

Sector -4,253,834.43%

Industry -4,253,834.43%

Operating Margin

-100.00%

Sector -36.74%

Industry -36.74%

Net Profit Margins

-100.00%

Sector -37.51%

Industry -37.51%

Asset Turnover

0.00

Sector 0.03

Industry 0.03

Profitability

ROE

-238.27%

Sector -61.50%

Industry -61.50%

ROA

-114.52%

Sector -63.85%

Industry -63.85%

ROIC

0.00%

Sector -498.30%

Industry -498.30%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

2.19

Sector 2.89

Industry 2.89

Net Debt / EBITDA

Sector -39,048,222.71

Industry -39,048,222.71

Net Debt / EBIT

Sector -10.24

Industry -10.24

Net Debt / Equity

0.00

Sector -0.60

Industry -0.60

Gross Debt / Equity

0.00

Sector -0.83

Industry -0.83

Equity/Assets

0.48

Sector 0.43

Industry 0.43

Liabilities/Assets

0.52

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-3.02%

Sector -

Industry -

5Y Earnings CAGR

-9.96%

Sector -

Industry -

Fundamentals ALGS

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
ALGS Aligos Therapeutics Inc.	$6.73	-40.60%	0.00%	-0.90	2.14	-238.27%	-100.00%
JNJ Johnson & Johnson	$266.50	55.29%	1.93%	31.09	7.70	24.76%	21.48%
PFE Pfizer Inc.	$27.87	21.03%	6.26%	35.86	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$256.91	27.42%	2.58%	74.16	-78.93	-106.44%	9.81%
NVO Novo Nordisk A/S	$45.62	-14.65%	3.95%	11.47	6.09	53.11%	35.32%
MRK Merck & Co. Inc.	$147.77	82.61%	2.24%	116.78	8.81	7.55%	4.76%
AZN AstraZeneca PLC	$161.98	3.71%	1.93%	24.59	5.10	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$66.29	45.78%	3.73%	14.81	6.16	41.55%	18.85%
ZTS Zoetis Inc.	$76.84	-49.43%	2.67%	12.20	10.25	84.02%	27.77%
REGN Regeneron Pharmaceuticals Inc.	$792.43	37.47%	0.44%	19.71	2.69	13.65%	27.86%
AMGN Amgen Inc.	$432.42	55.55%	2.22%	27.25	20.39	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$105.00	43.48%	0.00%	30.73	88.55	288.14%	24.86%
MCK McKesson Corporation	$897.16	31.93%	0.38%	19.60	-26.88	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$542.40	39.41%	0.00%	31.57	6.87	21.76%	35.00%
CAH Cardinal Health Inc.	$235.19	59.60%	0.88%	35.20	-20.39	-57.93%	0.62%
HRMY Harmony Biosciences Holdings Inc.	$39.29	3.26%	0.00%	12.32	2.23	18.14%	18.89%
BIIB Biogen Inc.	$217.24	59.31%	0.00%	38.68	1.71	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

ALGS Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Aligos Therapeutics

Aligos Therapeutics Inc.

Average Investor10 user rating

4.0 (1 people)

United States

8 years

Founded: 2018

2020

Time since IPO - 6 years

74

Employees

Aligos Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $68.15 million, with shareholders equity totaling $31.88 million.

The company employs approximately 74 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Aligos Therapeutics Inc. reported $3.74 million in revenue, generating net income of $-75.96 million.

Key financial metrics include a P/E ratio of -0.90, a price-to-book (P/B) ratio of 2.14, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ALGS.

Market cap

$68.15 million

Net worth

$31.88 million

$31,880,000.00

Assets

$66.33 million

$66,330,000.00

Total Shares Outstanding

10.00 million

10,000,000

Average Daily Trading Volume

$194.70 Thousand

$194,696.80

Sector

Health Care

Industry

Biotechnology

ALGS

ALGS revenue and profits

Financial Results ALGS

DRAG THE FRAME TO SEE MORE DATA

ALGS cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$897.16 31,33% (12M)

P/E

19.60

0.38%

ROE

-137.16%

P/BV

-26.88

CAH - Cardinal Health

$235.19 60,10% (12M)

P/E

35.20

0.88%

ROE

-57.93%

P/BV

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12M)

P/E

31.09

1.93%

ROE

24.76%

P/BV

7.70

ABBV - AbbVie

$256.91 26,00% (12M)

P/E

74.16

2.58%

ROE

-106.44%

P/BV

-78.93

MRK - Merck & Co.

$147.77 82,50% (12M)

P/E

116.78

2.24%

ROE

7.55%

P/BV

8.81

AZN - AstraZeneca

$161.98 3,46% (12M)

P/E

24.59

1.93%

ROE

20.74%

P/BV

5.10

PFE - Pfizer

$27.87 22,54% (12M)

P/E

35.86

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$897.16 31,33% (12 M)

P/L

19.60

0.38%

ROE

-137.16%

P/VP

-26.88

CAH - Cardinal Health

$235.19 60,10% (12 M)

P/L

35.20

0.88%

ROE

-57.93%

P/VP

-20.39

JNJ - Johnson & Johnson

$266.50 54,96% (12 M)

P/L

31.09

1.93%

ROE

24.76%

P/VP

7.70

ABBV - AbbVie

$256.91 26,00% (12 M)

P/L

74.16

2.58%

ROE

-106.44%

P/VP

-78.93

MRK - Merck & Co.

$147.77 82,50% (12 M)

P/L

116.78

2.24%

ROE

7.55%

P/VP

8.81

AZN - AstraZeneca

$161.98 3,46% (12 M)

P/L

24.59

1.93%

ROE

20.74%

P/VP

5.10

PFE - Pfizer

$27.87 22,54% (12 M)

P/L

35.86

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of Aligos Therapeutics (ALGS) today?

A cotação de Aligos Therapeutics (ALGS) hoje está em US$ 6.73, com uma variação de -38.93% em relação ao último ano. A cotação de Aligos Therapeutics (ALGS) iniciou o ano negociando na casa dos US$ 9.32 e hoje está em US$ 6.73. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Aligos Therapeutics (ALGS) e dados de ações do Ibovespa e mercados internacionais.

Quando Aligos Therapeutics (ALGS) paga dividendos?

Aligos Therapeutics (ALGS) não distribuiu dividendos no último ano.

Is Aligos Therapeutics (ALGS) a good investment?

Atualmente, Aligos Therapeutics (ALGS) está cotada a US$ 6.73, com um P/L de -0.90, representando um desvio de -817% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -38.93 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -38.93%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Aligos Therapeutics (ALGS) stock?

Investir em ações de Aligos Therapeutics (ALGS) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Aligos Therapeutics (ALGS) yield today?

A rentabilidade de Aligos Therapeutics (ALGS) foi de 54.54% no último mês, -38.93% no último ano e -98.37% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Aligos Therapeutics (ALGS) hoje, o investimento total seria de US$ 673.00, com base na cotação atual de US$ 6.73.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 411.00
Em 5 anos: US$ 10.97
Em 10 anos: US$ 673.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

ALGS

Aligos Therapeutics Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment ALGS

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING ALGS WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Aligos Therapeutics

Aligos Therapeutics Inc.

United States

8 years

2020

74

PROFIT X PRICE ALGS

Financial Results ALGS

ALGS cash flow

Asset, Revenue and Profit Growth - ALGS

ALGS balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions